Macrophages/NNS
in/IN
human/JJ
atheroma/NN
contain/VBP
PPARgamma/NN
:/:
differentiation-dependent/JJ
peroxisomal/JJ
proliferator-activated/JJ
receptor/NN
gamma/NN
(/(
PPARgamma/NN
)/)
expression/NN
and/CC
reduction/NN
of/IN
MMP-9/NN
activity/NN
through/IN
PPARgamma/NN
activation/NN
in/IN
mononuclear/JJ
phagocytes/NNS
in/FW
vitro/FW
./.

Mononuclear/JJ
phagocytes/NNS
play/VBP
an/DT
important/JJ
role/NN
in/IN
atherosclerosis/NN
and/CC
its/PRP$
sequela/NN
plaque/NN
rupture/NN
in/IN
part/NN
by/IN
their/PRP$
secretion/NN
of/IN
matrix/NN
metalloproteinases/NNS
(/(
MMPs/NNS
)/)
,/,
including/VBG
MMP-9/NN
./.
=====
Peroxisomal/JJ
proliferator-activated/JJ
receptor/NN
gamma/NN
(/(
PPARgamma/NN
)/)
,/,
a/DT
transcription/NN
factor/NN
in/IN
the/DT
nuclear/JJ
receptor/NN
superfamily/NN
,/,
regulates/VBZ
gene/NN
expression/NN
in/IN
response/NN
to/TO
various/JJ
activators/NNS
,/,
including/VBG
15-deoxy-delta12,14-prostaglandin/NN
J2/NN
and/CC
the/DT
antidiabetic/JJ
agent/NN
troglitazone/NN
./.
=====
The/DT
role/NN
of/IN
PPARgamma/NN
in/IN
human/JJ
atherosclerosis/NN
is/VBZ
unexplored/JJ
./.
=====
We/PRP
report/VBP
here/RB
that/IN
monocytes/macrophages/NNS
in/IN
human/JJ
atherosclerotic/JJ
lesions/NNS
(/(
n/NN
=/JJ
12/CD
)/)
express/VBP
immunostainable/JJ
PPARgamma/NN
./.
=====
Normal/JJ
artery/NN
specimens/NNS
(/(
n/NN
=/JJ
6/CD
)/)
reveal/VBP
minimal/JJ
immunoreactive/JJ
PPARgamma/NN
./.
=====
Human/JJ
monocytes/NNS
and/CC
monocyte-derived/JJ
macrophages/NNS
cultured/VBN
for/IN
6/CD
days/NNS
in/IN
5/CD
%/NN
human/JJ
serum/NN
expressed/VBD
PPARgamma/NN
mRNA/NN
and/CC
protein/NN
by/IN
reverse/JJ
transcription-polymerase/NN
chain/NN
reaction/NN
and/CC
Western/NN
blotting/NN
,/,
respectively/RB
./.
=====
In/IN
addition/NN
,/,
PPARgamma/NN
mRNA/NN
expression/NN
in/IN
U937/NN
cells/NNS
increased/VBN
during/IN
phorbol/NN
12-myristate/NN
13/CD
acetate-induced/JJ
differentiation/NN
./.
=====
Stimulation/NN
of/IN
PPARgamma/NN
with/IN
troglitazone/NN
or/CC
15-deoxy-delta12,14-prostaglandin/NN
J2/NN
in/IN
human/JJ
monocyte-derived/JJ
macrophages/NNS
inhibited/VBD
MMP-9/NN
gelatinolytic/JJ
activity/NN
in/IN
a/DT
concentration-dependent/JJ
fashion/NN
as/IN
revealed/VBN
by/IN
zymography/NN
./.
=====
This/DT
inhibition/NN
correlates/VBZ
with/IN
decreased/VBN
MMP-9/NN
secretion/NN
as/IN
determined/VBN
by/IN
Western/NN
blotting/NN
./.
=====
Thus/RB
,/,
PPARgamma/NN
is/VBZ
present/JJ
in/IN
macrophages/NNS
in/IN
human/JJ
atherosclerotic/JJ
lesions/NNS
and/CC
may/MD
regulate/VB
expression/NN
and/CC
activity/NN
of/IN
MMP-9/NN
,/,
an/DT
enzyme/NN
implicated/VBN
in/IN
plaque/NN
rupture/NN
./.
=====
PPARgamma/NN
is/VBZ
likely/JJ
to/TO
be/VB
an/DT
important/JJ
regulator/NN
of/IN
monocyte/macrophage/NN
function/NN
with/IN
relevance/NN
for/IN
human/JJ
atherosclerotic/JJ
disease/NN
./.